Connecting you to content on EBSCOhost

Works matching IS 02704137 AND DT 2004 AND VI 60 AND IP 3

Results: 5

1

Endothelin A receptor blockade does not alter PSA secretion in prostate cancer cell linesDisclosure: Dr. Nelson is a scientific consultant to Abbott Laboratories. This arrangement is being managed by the University of Pittsburgh School of Medicine in accordance with its conflict of interest policies.

Published in:

Prostate, 2004, v. 60, n. 3, p. 175, doi. 10.1002/pros.20116

By:

Stefana Pecher;
Beth R. Pflug;
Alisa K.W. Brink;
Joel B. Nelson

Publication type:

Article

2

Polo‐like kinase 1 is overexpressed in prostate cancer and linked to higher tumor grades.

Published in:

Prostate, 2004, v. 60, n. 3, p. 240, doi. 10.1002/pros.20050

By:

Wilko Weichert;
Mathias Schmidt;
Volker Gekeler;
Carsten Denkert;
Carsten Stephan;
Klaus Jung;
Stefan Loening;
Manfred Dietel;
Glen Kristiansen

Publication type:

Article

3

Interleukin‐6 protects LNCaP cells from apoptosis induced by androgen deprivation through the Stat3 pathway.

Published in:

Prostate, 2004, v. 60, n. 3, p. 178, doi. 10.1002/pros.20045

By:

Soo Ok Lee;
Wei Lou;
Candace S. Johnson;
Donald L. Trump;
Allen C. Gao

Publication type:

Article

4

Prostein expression is highly restricted to normal and malignant prostate tissues.

Published in:

Prostate, 2004, v. 60, n. 3, p. 246, doi. 10.1002/pros.20043

By:

Michael Kalos;
Jon Askaa;
Bonnie L. Hylander;
Elisabeth A. Repasky;
Feng Cai;
Thomas Vedvick;
Steven G. Reed;
George L. Wright;
Gary R. Fanger

Publication type:

Article

5

Antisense MDM2 oligonucleotides restore the apoptotic response of prostate cancer cells to androgen deprivationThe contents are solely the responsibility of the authors and do not necessarily represent the official views of the National Cancer Institute or the US Department of Defense.

Published in:

Prostate, 2004, v. 60, n. 3, p. 187, doi. 10.1002/pros.20044

By:

Zhaomei Mu;
Paul Hachem;
Sudhir Agrawal;
Alan Pollack

Publication type:

Article